Pancreatic expression of γ-interferon (IFN-γ) initiates a cascade of pathogenic changes that include pancreatic inflammation, islet cell destruction, hyperglycemia, and islet regeneration. In this study, we explore the developmental plasticity of the adult pancreas and particularly its ability to return to normoglycemia and to remodel itself from an advanced pathogenic state. This was approached by treating adult transgenic mice with a pulse of anti–IFN-γ antibody and determining the functional and morphological status of the pancreas. We demonstrated that anti–IFN-γ antibody administration led to the reduction of hyperglycemic blood glucose levels in transgenic mice. We also observed that the pancreas returned from a profoundly perturbed state toward normality. Analysis of the mitotic index indicated that cell proliferation previously associated with islet cell regeneration was greatly reduced after anti–IFN-γ administration. Our results highlight the ability of the adult pancreas to remodel itself and return from a complex pathological state to normalcy once the trophic signal inducing this pathology is removed. These data also suggest that anti–IFN-γ administration may have important clinical implications for treatment of chronic pancreatitis in humans.
Skip Nav Destination
Article navigation
Original Articles|
October 01 1995
Treatment of IFN-γ Transgenic Mice With Anti–IFN-γ Reveals the Remodeling Capacity of the Adult Pancreas
Danling Gu;
Danling Gu
Department of Neuropharmacology, The Scripps Research Institute
La Jolla
Search for other works by this author on:
Leslie Molony;
Leslie Molony
Tanabe Research Laboratories
San Diego, California
Search for other works by this author on:
Troy Krahl;
Troy Krahl
Department of Neuropharmacology, The Scripps Research Institute
La Jolla
Search for other works by this author on:
Nora Sarvetnick
Nora Sarvetnick
Department of Neuropharmacology, The Scripps Research Institute
La Jolla
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Nora Sarvetnick, Department of Neuropharmacology CVN-10, The Scripps Research Institute, 10666 North Torrey Pines Rd., La Jolla, CA 92037.
1
IFN-γ γ-interferon; PBS, phosphate-buffered saline.
Diabetes 1995;44(10):1161–1164
Article history
Received:
April 12 1995
Revision Received:
June 01 1995
Accepted:
June 01 1995
PubMed:
7556951
Citation
Danling Gu, Leslie Molony, Troy Krahl, Nora Sarvetnick; Treatment of IFN-γ Transgenic Mice With Anti–IFN-γ Reveals the Remodeling Capacity of the Adult Pancreas. Diabetes 1 October 1995; 44 (10): 1161–1164. https://doi.org/10.2337/diab.44.10.1161
Download citation file:
32
Views